These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 11317942

  • 1. Characterization and determination of the complex between prostate-specific antigen and alpha 1-protease inhibitor in benign and malignant prostatic diseases.
    Zhang WM, Finne P, Leinonen J, Stenman UH.
    Scand J Clin Lab Invest Suppl; 2000; 233():51-8. PubMed ID: 11317942
    [Abstract] [Full Text] [Related]

  • 2. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.
    Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O.
    Cancer Res; 1991 Jan 01; 51(1):222-6. PubMed ID: 1703033
    [Abstract] [Full Text] [Related]

  • 3. Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer.
    Finne P, Zhang WM, Auvinen A, Leinonen J, Määttänen L, Rannikko S, Tammela TL, Stenman UH.
    J Urol; 2000 Dec 01; 164(6):1956-60. PubMed ID: 11061890
    [Abstract] [Full Text] [Related]

  • 4. A multicenter clinical trial on the use of alpha1-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis.
    Lein M, Jung K, Hammerer P, Graefen M, Semjonow A, Stieber P, Ossendorf M, Luboldt HJ, Brux B, Stephan C, Schnorr D, Loening SA.
    Prostate; 2001 May 01; 47(2):77-84. PubMed ID: 11340629
    [Abstract] [Full Text] [Related]

  • 5. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F, Kwiatkowski MK, Piironen T, Pettersson K, Lümmen G, Wernli M, Wiefelspütz J, Graber SF, Goepel M, Huber A, Tscholl R.
    Cancer; 1998 Dec 15; 83(12):2540-7. PubMed ID: 9874461
    [Abstract] [Full Text] [Related]

  • 6. Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis.
    Lein M, Jung K, Elgeti U, Brux B, Sinha P, Schnorr D, Loening SA.
    Anticancer Res; 2000 Dec 15; 20(6D):4997-5001. PubMed ID: 11326657
    [Abstract] [Full Text] [Related]

  • 7. Measurement of the complex between prostate-specific antigen and alpha1-protease inhibitor in serum.
    Zhang WM, Finne P, Leinonen J, Vesalainen S, Nordling S, Stenman UH.
    Clin Chem; 1999 Jun 15; 45(6 Pt 1):814-21. PubMed ID: 10351990
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dual monoclonal antibody immunoassay for free prostate-specific antigen.
    Wang TJ, Hill TM, Sokoloff RL, Frankenne F, Rittenhouse HG, Wolfert RL.
    Prostate; 1996 Jan 15; 28(1):10-6. PubMed ID: 8545276
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME.
    Clin Lab Sci; 2001 Jan 15; 14(2):102-7. PubMed ID: 15625982
    [Abstract] [Full Text] [Related]

  • 12. Regulation of the enzymatic activity of prostate-specific antigen and its reactions with extracellular protease inhibitors in prostate cancer.
    Lilja H.
    Scand J Clin Lab Invest Suppl; 1995 Jan 15; 220():47-56. PubMed ID: 7544478
    [Abstract] [Full Text] [Related]

  • 13. [Changes of serum total PSA and free PSA in patients with prostate carcinoma and benign prostate hyperplasia].
    Gao ZW, Liu G, Sheng BW.
    Ai Zheng; 2004 Jun 15; 23(6):701-3. PubMed ID: 15191675
    [Abstract] [Full Text] [Related]

  • 14. Significance of different molecular forms of serum PSA. The free, noncomplexed form of PSA versus that complexed to alpha 1-antichymotrypsin.
    Lilja H.
    Urol Clin North Am; 1993 Nov 15; 20(4):681-6. PubMed ID: 7505976
    [Abstract] [Full Text] [Related]

  • 15. [Clinical utility of the free prostate specific antigen (PSA), alpha 1-antichymotrypsin-complexed PSA, and free/total PSA ratio using the specific and sensitive enzyme-linked immunosorbent assay "E-plate EIKEN PSA"].
    Imai K, Yamanaka H, Kubota Y, Miki M, Ito T, Akaza H, Uchida K, Egawa S, Kuriyama M, Watanabe H, Okihara K, Kotake T, Usami M, Arai Y, Maeda H, Sagiyama K, Saito Y, Sakai H, Shida K.
    Hinyokika Kiyo; 1998 Oct 15; 44(10):755-63. PubMed ID: 9850846
    [Abstract] [Full Text] [Related]

  • 16. IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging.
    Trojan L, Bode C, Weiss C, Mayer D, Grobholz R, Alken P, Michel MS.
    Eur Urol; 2006 Feb 15; 49(2):286-92; discussion 292. PubMed ID: 16386354
    [Abstract] [Full Text] [Related]

  • 17. [Diagnostic value of complexed prostate-specific antigen for prostate cancer].
    Su HW, Li Y, Xu P.
    Zhonghua Nan Ke Xue; 2003 Sep 15; 9(6):431-3. PubMed ID: 14574807
    [Abstract] [Full Text] [Related]

  • 18. Electrophoretic subforms of free prostate-specific antigen in serum as promising diagnostic tool in prostate cancer diagnostics.
    Jung K, Hoesel W, Reiche J, Deger S, Kramer J, Loening SA, Lein M, Stephan C.
    Urology; 2007 Feb 15; 69(2):320-5. PubMed ID: 17320672
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic validity of macrophage migration inhibitory factor in serum of patients with prostate cancer: a re-evaluation.
    Michael A, Stephan C, Kristiansen G, Burckhardt M, Loening SA, Schnorr D, Jung K.
    Prostate; 2005 Jan 01; 62(1):34-9. PubMed ID: 15389818
    [Abstract] [Full Text] [Related]

  • 20. Differential percentage of serum prostate-specific antigen subforms suggests a new way to improve prostate cancer diagnosis.
    Sarrats A, Comet J, Tabarés G, Ramírez M, Aleixandre RN, de Llorens R, Peracaula R.
    Prostate; 2010 Jan 01; 70(1):1-9. PubMed ID: 19670261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.